Universitair Ziekenhuis Antwerpen
Universitair Ziekenhuis Antwerpen
Antwerp, Belgium9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Recruiting | Not applicable | 2026-09-21 | NCT07227805 | |
| Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electromyography-driven Serious Game. | Hospital Associated Disability; Immobility; Older Adults (65 Years and Older) | Recruiting | Phase 2 | 2026-09-15 | NCT07294131 | |
| Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 3 | 2026-07-08 | NCT04685616 | |
| Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 3 | 2026-07-06 | NCT05948475 | |
| Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-03-05 | NCT06667960 | |
| A Multicentric European Study to Promote Clinical Trial Readiness for STXBP1-related Disorders | brain disorder, central nervous system disorder, developmental and epileptic encephalopathy, 4, epilepsy, nervous system disorder | Recruiting | Not stated | 2026-02-06 | NCT06625112 | |
| Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial) | Transplant Complication | Recruiting | Phase 2 | 2024-12-27 | NCT05762211 | |
| Subcutaneous Infliximab After A Previous Intravenous Dose Optimization | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 4 | 2024-07-26 | NCT06113913 | |
| The European NAFLD Registry | Body Weight, Digestive System Diseases, Digestive System Neoplasms, Dyslipidemias, Fibrosis, Fibrosis, Liver, Lipid Metabolism Disorders, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Steatohepatitis, adenocarcinoma, carcinoma, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, epithelial neoplasm, fatty liver disease, glucose metabolism disease, hepatocellular carcinoma, hypertensive disorder, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, neoplasm, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorder | Recruiting | Not stated | 2023-01-06 | NCT04442334 |